Boyu Zhu

Dr. Boyu Zhu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
ZZZiyi Zhao
Ziyi Zhao
JCJiayi Cao
Jiayi Cao
BZBoyu Zhu
Boyu Zhu
XLXinru Li
Xinru Li
LZLin Zhou
Lin Zhou
BSBin Su
Bin Su
MXene is a new family of two-dimensional nanomaterials with outstanding electrical conductivity, tunable structure, biocompatibility, and a large surface area. Thanks to these unique physicochemical properties, MXene has been used for constructing electrochemical sensors (MECSens) with excellent performance. In particular, the abundant surface termination of MXene can contribute to greatly enhancing the analytical sensitivity and selectivity of MECSens. Recently, MECSens have been widely applied in many fields including clinical diagnosis, infectious disease surveillance, and food security. However, not all MXene materials are suitable for building electrochemical sensors. In this article, we present an overview of different MECSens that have been developed so far. We begin with a short summary of the preparation and characterization of MECSens. Subsequently, the electrochemical performance, detection strategies, and application scenarios of MECSens are classified and briefly discussed. The article ends with a short conclusion and future perspectives. We hope this article will be helpful for designing and constructing MECSens with outstanding activity for electrochemical analysis.

29 September 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
SQShaohong Qu
Shaohong Qu
BZBoyu Zhu
Boyu Zhu
ZLZihao Liu
Zihao Liu
XCXing Chen
Xing Chen
PDPeifang Dong
Peifang Dong
ZLZhu Lihang
Zhu Lihang
Personalized, point-of-care testing of human tears is essential for ocular disease diagnosis, yet it is hampered by picomolar biomarker levels and microliter sample volumes. In this work, we developed an integrated, portable electrochemiluminescence (ECL)-based device for rapid and quantitative detection of tumor necrosis factor alpha (TNF-α), a pivotal inflammatory marker in ocular surface disease, with particular relevance to dry eye syndrome (DES). The device integrates a miniaturized electrochemical cell for ECL reactions and a compact silica photomultiplier for signal measurement. A vertical silica mesochannel (VSM)-coated ITO electrode is also integrated and further functionalized with TNF-α-specific aptamers. The VSM enables the enrichment of ECL luminophores, thus enabling further amplification of ECL signals and enhancing sensitivity. A wide linear range from 0.1 to 200 pg/mL was achieved using 10-fold dilution of 3 μL tear samples. Overall, this study provides a portable, highly sensitive platform for personalized analysis of TNF-α in tear fluid, enabling rapid point-of-care assessment of DES.